Composite Score Weighting for Higher-Power Clinical Trials
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing clinical trial designs face challenges in optimizing composite assessments for diseases with multiple symptoms, leading to inefficiencies in statistical power and endpoint evaluation, particularly due to equal weighting of components regardless of their impact on patients.
Innovation Solution
The use of generative models, such as digital twins and neural networks, to optimize item scores and derive composite scores that minimize variance and tailor weights based on disease progression and patient-specific data, enhancing statistical power and decision-making in clinical trials.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If equal weighting is applied to all composite assessment items, then the assessment structure remains simple and easy to implement, but the statistical power and ability to detect treatment effects are reduced
Solution Approach 1:
The patent transforms the fixed equal-weight parameter into dynamic optimized weights by applying mean-variance analysis. This mathematical optimization method calculates weights that maximize the signal-to-noise ratio of the composite score, thereby enhancing statistical power while maintaining computational feasibility through established statistical techniques.
Solution Approach 2:
The patent assigns different weights to different assessment items based on their individual contributions to disease severity and treatment detection. Rather than uniform treatment of all items, each item receives a localized weight optimized for its specific clinical relevance, allowing the composite score to better capture nuanced treatment effects.
2Adaptability or versatility
If composite assessments evaluate multiple disease dimensions, then the comprehensiveness of disease evaluation improves, but the variance of composite scores increases reducing statistical power
Solution Approach 1:
The patent applies mean-variance analysis to dynamically adjust the weights of multiple assessment items, transforming a high-variance multi-dimensional evaluation into a optimized composite score. This mathematical approach selects and weights items to maximize information content while minimizing variance, enabling comprehensive disease evaluation with enhanced statistical power.
3Adaptability or versatility
If more items are included in composite assessments to capture varied symptoms, then the assessment coverage improves, but the complexity of score optimization and calculation increases
Solution Approach 1:
The patent employs mean-variance analysis to optimize weights across multiple assessment items, transforming a complex multi-item evaluation into a streamlined optimized composite score. This mathematical optimization efficiently handles the complexity by applying systematic weight calculation methods that scale well with the number of items, maintaining computational feasibility while capturing comprehensive symptom information.
Data Source
AI summary
Systems and methods for deriving composite scores are illustrated. One embodiment includes a method for optimizing a clinical trial configuration. The method derives item scores for each of a plurality of subjects where each: is based subject data corresponding to a randomized control trial; and answers items from a medical evaluation. The method identifies a parameter to optimize vectors of item weights, wherein: the vectors of item weights are derived using a mean-variance analysis; and each includes a non-negative number. The method determines, for each of the plurality of subjects, an initial composite score, from: one of the at least one vector of item weights; and the plurality of item scores. A resulting collection of composite scores includes the initial composite score determined for each of the plurality of subjects. The method applies the resulting collection of composite scores to implementing a clinical trial.